India's New Trilemma

...Kids, jobs, emigration, notes Ajit Balakrishnan. Illustration: Dominic Xavier/Rediff.com   "Aren't you kids going to have children?" I asked one of my nieces who had come for a one-week......

Covid Vaccine IP: How Big Pharma lobbied against India

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual......

'Swine flu spreading through locals, among locals'

"There is no panic about the swine flu in Gujarat. We have assured quick diagnosis and quicker treatment up to the district level. We are taking the pandemic very seriously. So far, of all the......

After 15 years, Ranjit Shahani steps down as Novartis' India chief

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......

Studying at ISB to cost over Rs 20 lakh

The Indian School of Business, ranked in the top 12 global B-schools by the Financial Times, has increased its tuition fee to Rs 15.3 lakh (Rs 1.53 million) per annum -- Rs 80,000 more than Rs 14.5......

Novartis ruling to impact innovation: US biz groups

Business groups in the US have sharply criticised the Supreme Court of India judgment against Swiss drugmaker Novartis in denying patent protection to the company’s anti-cancer drug......

Abbott Labs sues Ranbaxy

Abbott Laboratories is suing India's Ranbaxy Laboratories as well as Israel's Teva and Sandoz of the Novartis group, in Chicago for allegedly violating its patents protecting Omnicef, a drug used......